Teva Pharmaceutical Industries Ltd (TEVJF)
11.75
0.00 (0.00%)
USD |
OTCM |
May 14, 16:00
Teva Pharmaceutical Industries Price to Book Value: 1.829 for May 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 14, 2024 | 1.829 |
| May 13, 2024 | 1.829 |
| May 10, 2024 | 1.829 |
| May 09, 2024 | 1.829 |
| May 08, 2024 | 1.829 |
| May 07, 2024 | 1.829 |
| May 06, 2024 | 1.829 |
| May 03, 2024 | 1.829 |
| May 02, 2024 | 1.829 |
| May 01, 2024 | 1.829 |
| April 30, 2024 | 1.829 |
| April 29, 2024 | 1.829 |
| April 26, 2024 | 1.829 |
| April 25, 2024 | 1.829 |
| April 24, 2024 | 1.829 |
| April 23, 2024 | 1.829 |
| April 22, 2024 | 1.829 |
| April 19, 2024 | 1.829 |
| April 18, 2024 | 1.864 |
| April 17, 2024 | 1.864 |
| April 16, 2024 | 1.864 |
| April 15, 2024 | 1.864 |
| April 12, 2024 | 2.060 |
| April 11, 2024 | 2.060 |
| April 10, 2024 | 2.060 |
| Date | Value |
|---|---|
| April 09, 2024 | 2.060 |
| April 08, 2024 | 2.218 |
| April 05, 2024 | 2.218 |
| April 04, 2024 | 2.179 |
| April 03, 2024 | 2.179 |
| April 02, 2024 | 2.179 |
| April 01, 2024 | 2.179 |
| March 31, 2024 | |
| March 28, 2024 | 2.091 |
| March 27, 2024 | 2.091 |
| March 26, 2024 | 1.971 |
| March 25, 2024 | 1.971 |
| March 22, 2024 | 1.971 |
| March 21, 2024 | 1.971 |
| March 20, 2024 | 1.971 |
| March 19, 2024 | 1.971 |
| March 18, 2024 | 1.971 |
| March 15, 2024 | 1.971 |
| March 14, 2024 | 1.971 |
| March 13, 2024 | 1.847 |
| March 12, 2024 | 1.847 |
| March 11, 2024 | 1.847 |
| March 08, 2024 | 1.847 |
| March 07, 2024 | 1.847 |
| March 06, 2024 | 1.847 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3168
Minimum
Oct 07 2019
2.218
Maximum
Apr 05 2024
1.092
Average
1.057
Median
Nov 19 2020
Price to Book Value Benchmarks
| Compugen Ltd | 3.011 |
| Pluri Inc | -- |
| BioLine Rx Ltd | 3.777 |
| Can Fite Biofarma Ltd | 1.719 |
| BiomX Inc | 6.363 |
Price to Book Value Related Metrics
| PS Ratio | 0.8255 |
| Price to Free Cash Flow | 15.05 |
| Price | 11.75 |
| Earnings Yield | -3.49% |
| Market Cap | 13.31B |
| Operating PE Ratio | 3.970 |
| Normalized PE Ratio | 6.102 |